What's so Great About TMC114? - a podcast by TheBody.com

from 2021-09-09T06:57:59.661991

:: ::

TheBody.com interviewed Dr. Cal Cohen, one of the lead researchers who investigated TMC114 (darunavir, Prezista) in clinical trials, to get his take on some of the key questions surrounding this new HIV medication: Why should we be so excited about TMC114? What side effects can it cause? How is it likely to change the way HIVers with multidrug resistance are treated?